Electronic Cigarette Use
53
8
9
39
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.9%
1 terminated out of 53 trials
97.5%
+11.0% vs benchmark
4%
2 trials in Phase 3/4
21%
8 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (53)
Cessation of Smoking Trial in the Emergency Department
Development of UP2UTobacco for High School Youth
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
The Avenues Study: Dual Use Cessation
Effect of Cannabis on E-Cigarette Use Behavior
Effect of Menthol on ENDS Users' Addiction and Exposure
Developing and Testing Health Warning Labels on the ENDS Device
Assessing Electronic Cigarette Nicotine Flux
Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening
The Impact of Oral Ethanol and Vaped Ethanol on the Evaluation of Impairment
Effects of E-cigarette Use on Health
Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use
CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes
E-cigarettes for Harm Reduction in Adults With Asthma
Assessing the Effect of Nicotine Reduction on ENDS User's Addiction and Exposures
Dual Use of ENDS and Combustible Cigarettes
CSD201203: A Study to Determine Subject Puffing Patterns of a Non-cylindrical, Closed, Electronic Nicotine Delivery System at Three Nicotine Concentrations in an Ambulatory Setting
Nicotine and Cannabis Vape Labeling Experiment - Spring 2025
Dual Use Approach Bias Training for Nicotine Addiction
Effects of E-Cigarette Nicotine Content in Smokers (Nicotine Flux Study)